DNA Aptamer Evolved by Cell-SELEX for Recognition of Prostate Cancer

Morbidity and mortality of prostate cancer (PCa) have increased in recent years worldwide. Currently existing methods for diagnosis and treatment do not make the situation improve, especially for hormone refractory prostate cancer (HRPC). The lack of molecular probes for PCa hindered the early diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuanyuan, Luo, Yun, Bing, Tao, Chen, Zheng, Lu, Minhua, Zhang, Nan, Shangguan, Dihua, Gao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067300/
https://www.ncbi.nlm.nih.gov/pubmed/24956390
http://dx.doi.org/10.1371/journal.pone.0100243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067300/
https://www.ncbi.nlm.nih.gov/pubmed/24956390
http://dx.doi.org/10.1371/journal.pone.0100243

Ejemplares similares